Heartflow (HTFL) EBIT Margin (2024 - 2025)
Heartflow's quarterly EBIT Margin came in at 44.32% in Q4 2025, down 2755.0% year-on-year from 1.67% in Q4 2024, and up 235.83% quarter-over-quarter from 32.63% in Q3 2025.
Heartflow has reported EBIT Margin for 2 years, with the latest figure at 44.32% in Q4 2025.
- For the quarter ending Q4 2025, EBIT Margin fell 2755.0% year-over-year to 44.32%; the trailing twelve-month figure through Dec 2025 stood at 10.41% (changed N/A YoY), and the FY2025 full-year result was 13.94%, up 198.0% from the prior year.
- EBIT Margin for Q4 2025 stood at 44.32%, up from 32.63% in the prior quarter.
- The five-year high for EBIT Margin was 71.87% in Q4 2024, with the low at 45.65% in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 29.41% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 29.03% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 17.59% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 17.08% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 25.64% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -11.30% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 1.23% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 5.44% |
| 10 | Heartflow | 1.15 Bn | 974.90 Mn | 39.06 Mn | 44.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44.32% |
| Sep 30, 2025 | -32.63% |
| Jun 30, 2025 | -31.58% |
| Dec 31, 2024 | 71.87% |
| Sep 30, 2024 | -45.33% |
| Jun 30, 2024 | -45.65% |